FZD2 and hepatocellular carcinoma: Asano T et al. 25 demonstrated that FZD2 is highly expressed in hepatocellular cancer tissues compared to adjacent tissues and that patients with a mesenchymal tumor in which FZD2 expression was significantly higher than in the epithelial tumor were more prone to experiencing earlier recurrence compared with those with an epithelial tumor.